Stocks of the Hour: Neuren Pharmaceuticals, Green Technology Metals, One Click Group
Neuren Pharmaceuticals (ASX:NEU) announced the expansion of its partnership with Acadia Pharmaceuticals (NASDAQ:ACAD). Neuren is set to receive US$100 million up-front, plus additional potential milestone payments of up to US$427 million, plus royalties. Shares are trading 16.75 per cent higher at $13.59. Green Technology Metals (ASX:GT1) has announced that their assay results at their Root […]
Stocks of the Hour: Neuren Pharmaceuticals, Green Technology Metals, One Click Group Read More »


